Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127053871 | 12705387 | 1 | I | 20160826 | 20160901 | 20160901 | EXP | AU-AMGEN-AUSCT2016113205 | AMGEN | R.L O^CONNELL. TACTIC: A MULTICENTRE, OPEN-LABEL, SINGLE-ARM PHASE II TRIAL OF PANITUMUMAB, CISPLATIN, AND GEMCITABINE IN BILIARY TRACT CANCER.. CANCER CHEMOTHER PHARMACOL.. 2016;78:361-367 | 0.00 | Y | 0.00000 | 20160831 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127053871 | 12705387 | 1 | PS | panitumumab | PANITUMUMAB | 1 | Unknown | 9 MG/KG, ON DAY 1 OF EACH CYCLE | U | 125147 | 9 | MG/KG | UNKNOWN FORMULATION | ||||||
| 127053871 | 12705387 | 2 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | 1000 MG/M2 ON DAY 1 AND DAY 8 OF EACH 21-DAY CYCLE | 0 | 1000 | MG/M**2 | ||||||||
| 127053871 | 12705387 | 3 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | 25 MG/M2, ON DAY AND DAY 8 OF EACH 21-DAY CYCLE | 0 | 25 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127053871 | 12705387 | 1 | Bile duct cancer |
| 127053871 | 12705387 | 2 | Bile duct cancer |
| 127053871 | 12705387 | 3 | Bile duct cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127053871 | 12705387 | OT |
| 127053871 | 12705387 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127053871 | 12705387 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |